Anti-PDL2 (soluble form) [Z64P2D3*H4] mAb

Monoclonal antibody which can aid understanding of programmed death ligand 2, in the secreted form.

Contributors

Inventor Institute
Ayham Alnabulsi Vertebrate Antibodies Limited
Cat. #: 152795
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Immunology
Application: ELISA ; IHC ; WB
Target: Programmed Cell Death 1 Ligand 2 (PDL2-Soluble form)
Reactivity: Human
Clone: Z64P2D3*H4
Host: Mouse
Class: Monoclonal
Alternate name: B7 dendritic cell molecule, B7-DC, B7DC, bA574F11.2, Btdc, Butyrophilin B7 DC, Butyrophilin B7-DC, Butyrophilin B7DC, CD 273, CD273, CD273 antigen, MGC142238, MGC14224, PD 1 ligand 2, PD L2, PD-1 ligand 2, PD-L2, PD1 ligand 2, PD1L2_HUMAN, PDCD 1 ligand 2, PDCD1 ligand 2
Product description: Monoclonal antibody which can aid understanding of programmed death ligand 2, in the secreted form. Background and Research Application PDL2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.). PDL2 is an immune checkpoint receptor ligand which plays a role in negative regulation of the adaptive immune response.PD-L2 is one of two known ligands for Programmed cell death protein 1 (PD-1). PD-1, is a key immune checkpoint. Currently several anti-PD-1 antibodies or blockers are in cancer clinical trials and showing promising outcomes. This antibody will allow scientists examine, for the first time, the clinical significance of PDL2-secreted form.
Conjugation: Unconjugated
Isotype: IgG2b kappa
Immunogen: Ovalbumin-conjugated synthetic peptide KAVFFKRHN
Immunogen Uniprot ID: Q9BQ51
Myeloma used: P3X63Ag8.653
Target background: Monoclonal antibody which can aid understanding of programmed death ligand 2, in the secreted form. Background and Research Application PDL2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.). PDL2 is an immune checkpoint receptor ligand which plays a role in negative regulation of the adaptive immune response.PD-L2 is one of two known ligands for Programmed cell death protein 1 (PD-1). PD-1, is a key immune checkpoint. Currently several anti-PD-1 antibodies or blockers are in cancer clinical trials and showing promising outcomes. This antibody will allow scientists examine, for the first time, the clinical significance of PDL2-secreted form.
Format: Liquid
Concentration: 1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
Shipping conditions: Dry ice

Related Tools for Antibodies

Cat. # Tool Name
151017 Anti-MBP [R29.6] Key Info View Tool
151021 Anti-CyclinB1 [V152] Key Info View Tool
151026 Anti-FCGR1 [10.1] mAb Key Info View Tool
151031 Anti-RuvA [RuvA 12C6] Key Info View Tool
151033 Anti-HSVUL42 [13C9] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.